Pearlcam

Before a new cancer drug or imaging agent can be tested on humans, it must be proven effective and safe in animal models. Systems like the LI-COR Pearl Trilogy provide the high-quality data required by regulatory bodies (like the FDA) to move a discovery from the lab to the clinic.

Biological tissues naturally glow under certain light; the NIR range used by PearlCAM minimizes this "noise," resulting in much clearer images.

PearlCAM is the proprietary interface used to capture and analyze high-resolution images in the spectrum. Unlike visible light, NIR light can penetrate several centimeters into biological tissue, allowing for: PearlCAM

In the rapidly evolving landscape of cancer research, the ability to visualize biological processes in real-time within living organisms is paramount. PearlCAM (and the associated Pearl imaging systems) serves as a bridge between laboratory benchwork and clinical application, providing researchers with a non-invasive look at tumor progression and drug delivery. 🔬 Core Technology

Because the imaging is non-invasive, researchers can scan the same animal over days or weeks. This reduces the number of animals needed for a study and provides a more accurate timeline of how a tumor grows or shrinks in response to treatment. 🛠 Features and Workflow Before a new cancer drug or imaging agent

Capabilities typically include 700 nm and 800 nm channels, allowing researchers to track two different biological markers simultaneously. 📈 Key Applications in Research

The workflow for a research team using PearlCAM typically follows three stages: PearlCAM is the proprietary interface used to capture

High-sensitivity detection of signals from within internal organs or deep-seated tumors.